DepYmed Inc. is a New York-based cancer and rare disease therapeutic development company. DepYmed is currently developing potent inhibitors of the enzyme PTP1B (protein tyrosine phosphatase 1B) as potential novel therapeutics for HER2-positive breast cancer and Rett Syndrome.
Bristol-Myers Squibb
259 followers
Astellas Pharma
42 followers
NYU Langone Health
26 followers
West Pharmaceutical Services
8 followers
Curia Global
6 followers
AbbVie
277 followers
Navitus Health
4 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies